We are live on ! Find out more
GSC

G&S Capital Portfolio holdings

AUM $345M
1-Year Est. Return 32.53%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+32.53%
3 Year Est. Return
+77.18%
5 Year Est. Return
+99.48%
10 Year Est. Return
AUM
$177M
AUM Growth
+$5.72M
Cap. Flow
-$1.67M
Cap. Flow %
-0.94%
Top 10 Hldgs %
33.45%
Holding
254
New
31
Increased
61
Reduced
58
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 13.01%
2 Consumer Staples 7.9%
3 Healthcare 7.01%
4 Financials 4.66%
5 Industrials 3.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
151
PepsiCo
PEP
$190B
$33K 0.02%
246
-125
-34% -$17K
ABT icon
152
Abbott
ABT
$183B
$31K 0.02%
365
+62
+20% +$5.19K
XYZ
153
Block Inc
XYZ
$48.4B
$31K 0.02%
500
DUK icon
154
Duke Energy
DUK
$97.8B
$30K 0.02%
335
GWW icon
155
W.W. Grainger
GWW
$65.3B
$30K 0.02%
90
HOG icon
156
Harley-Davidson
HOG
$2.58B
$26K 0.01%
724
RPM icon
157
RPM International
RPM
$13.7B
$23K 0.01%
308
SDY icon
158
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$23K 0.01%
221
PNR icon
159
Pentair
PNR
$10.4B
$22K 0.01%
490
+1
+0.2% +$42
ENB icon
160
Enbridge
ENB
$119B
$19K 0.01%
494
FRT icon
161
Federal Realty Investment Trust
FRT
$10.7B
$19K 0.01%
152
-1
-0.7% -$133
DD icon
162
DuPont de Nemours
DD
$18.5B
$18K 0.01%
231
+1
+0.4% +$83
ZM icon
163
Zoom
ZM
$28.2B
$18K 0.01%
270
-100
-27% -$6.88K
PRU icon
164
Prudential Financial
PRU
$42.4B
$17K 0.01%
189
+145
+330% +$13.3K
WBA
165
DELISTED
Walgreens Boots Alliance
WBA
$17K 0.01%
300
+2
+0.7% +$115
DOW icon
166
Dow Inc
DOW
$21.9B
$16K 0.01%
299
+4
+1% +$207
NVCR icon
167
NovoCure
NVCR
$1.73B
$16K 0.01%
200
AMP icon
168
Ameriprise Financial
AMP
$48.3B
$15K 0.01%
+93
New +$14.4K
CRSP icon
169
CRISPR Therapeutics
CRSP
$4.73B
$15K 0.01%
250
NE
170
DELISTED
Noble Corporation
NE
$15K 0.01%
+12,800
New +$15.3K
SLB icon
171
SLB Ltd
SLB
$73.6B
$14K 0.01%
358
WELL icon
172
Welltower
WELL
$169B
$14K 0.01%
182
-45,867
-100% -$3.93M
EWZ icon
173
iShares MSCI Brazil ETF
EWZ
$9.28B
$13K 0.01%
275
NVO
174
Novo Nordisk
NVO
$208B
$13K 0.01%
452
EOG icon
175
EOG Resources
EOG
$79.2B
$11K 0.01%
135

Similar funds

G&S Capital's Q4 2019 Portfolio in Review

As of Q4 2019, G&S Capital held 254 positions worth $177M, up 3.3% from $172M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

G&S Capital's Q4 2019 filing shows 31 new, 61 increased, 58 reduced and 30 closed positions. Its largest new stake was Merck: 46,684 shares worth $4.05M. The largest sale was First Trust Enhanced Short Maturity ETF, an estimated $5.85M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.8% a quarter earlier, followed by Consumer Staples and Healthcare.

  • G&S Capital's largest Q4 2019 buy was Merck: 46,684 shares worth $4.05M.
  • G&S Capital added most to Texas Instruments in Q4 2019, an estimated $4.07M increase.
  • G&S Capital's biggest Q4 2019 reduction was First Trust Enhanced Short Maturity ETF, cutting an estimated $5.85M.
  • G&S Capital fully exited FirstEnergy in Q4 2019, selling an estimated $3.81M.
  • G&S Capital's ten largest holdings make up 33% of its $177M portfolio in Q4 2019.
  • G&S Capital opened 31 new positions and closed 30 in Q4 2019.
  • G&S Capital's portfolio value rose 3.3% quarter-over-quarter to $177M.

Based on G&S Capital's 13F filing for Q4 2019, filed 21 Jan 2020.